The FDA's expert panel just gave a thumbs-up for Pfizer's COVID-19 vaccine in younger children, clearing the path for authorization in a matter of days

The FDA's expert panel just gave a thumbs-up for Pfizer's COVID-19 vaccine in younger children, clearing the path for authorization in a matter of days

Business Insider

Published

Younger children between 5 and 11 years old could start getting the Pfizer-BioNTech coronavirus vaccine as soon as early November.

Full Article